Participating Faculty

Supplements and Featured Publications, Economic Impact of Irritable Bowel Syndrome: What Does the Future Hold?, Volume 11, Issue 1 Suppl

The American Journal of Managed Care

This supplement to contains information regarding the economic and medical impact of irritable bowel syndrome. This supplement has been reviewed by an expert in the field.


Daniel Aguilar, MPH

Cerner Health Insights

Associate Director

Novartis Pharmaceuticals Corporation

Senior Clinical Analyst

Blue Bell, Pennsylvania

Judith Bentkover, PhD

Innovative Health Solutions

Senior Consultant

Brookline, Massachusetts

Stephen J. Boccuzzi, PhD

Aetna Health Information Solutions

Assistant Professor of Medicine

Bethesda, Maryland

Bonnie B. Dean, PhD

Cerner Health Insights

Senior Analyst

Blue Bell, Pennsylvania

Feride Frech, MPH

Health Economics and Outcomes Research

East Hanover, New Jersey

Ian M. Gralnek, MD, MSHS

David Geffen School of Medicine

VA Greater Los Angeles Healthcare System

Center for the Study of Digestive Healthcare Quality and Outcomes

Vice President

Detroit, Michigan

Samuel Joo, MS

Aetna Health Information Solutions


Novartis Pharmaceuticals Corporation


Brookline, Massachusetts

Joshua J. Ofman, MD

Reimbursement and Payment Policy

Thousand Oaks, California

Dean G. Smith, PhD

Department of Health Management and Policy

School of Public Health

Assistant Professor of Medicine

VA Greater Los Angeles Healthcare System

University of California Los Angeles

Los Angeles, California

Judith J. Stephenson, SM

Aetna Health Information Solutions

President and Chief Executive Officer

Scottsdale, Arizona

Faculty Disclosure

The American Journal of Managed Care

It is the policy of to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest.

These participants have declared no financial affiliations with any corporate organizations:

  • Daniel Aguilar, MPH
  • Judith Bentkover, PhD
  • Stephen J. Boccuzzi, PhD
  • Joaquim Fernandes, BA
  • Samuel Joo, MS
  • Joshua J. Ofman, MD
  • Brennan M. R. Spiegel, MD, MSHS
  • Sean Sullivan, JD

These participants are employed by Novartis Pharmaceuticals:

  • Victoria Barghout, MSPH
  • Kristijan H. Kahler, SM

These participants have disclosed the following relationships with corporate organizations:

  • Brooks Cash, MD, FACP Consultant To: Novartis Pharmaceuticals

Research Support From:

  • AstraZeneca
  • Janssen and Eisai
  • Roche TAP

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg, New Jersey.

This program is supported by an educational grant from Novartis Pharmaceuticals.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.